27924297|t|Datasets for the validation of the " in vivo " siRNA - silencing of CD40 and for the detection of new markers of atherosclerosis progression in ApoE - deficient mice
27924297|a|Data presented in this Data in Brief article correspond to the article " in vivo " silencing of CD40 reduces progression of experimental atherogenesis through a NFκB / miR-125b axis and reveals new potential mediators in the pathogenesis of atherosclerosis " (M. Hueso, L. De Ramon, E. Navarro, E. Ripoll, J.M. Cruzado, J.M. Grinyo, J. Torras, 2016) [1]. Here, we describe the validation of the silencing of CD40 expression with a specific siRNA in ApoE(-/-) mouse aortas, and its systemic effects on splenic lymphocytic subpopulations as well as on the infiltration of aortic intima by F4/80(+), galectin-3(+) macrophages or by NF-κB(+) cells. We also show the output of a Gene Ontology and TLDA analysis which allowed the detection of potential mediators of atherosclerosis progression. We provide the scientific community with a set of genes whose expression is increased during atherosclerosis progression but downregulated upon CD40 silencing.
27924297	0	8	Datasets	T170	UMLS:C0150098
27924297	17	27	validation	T062	UMLS:C1519941
27924297	37	44	in vivo	T082	UMLS:C1515655
27924297	47	52	siRNA	T103	UMLS:C1099354
27924297	55	64	silencing	T038	UMLS:C0598496
27924297	68	72	CD40	T017	UMLS:C1539081
27924297	85	94	detection	T058	UMLS:C1511790
27924297	102	109	markers	T038	UMLS:C0017393
27924297	113	128	atherosclerosis	T038	UMLS:C0003850
27924297	129	140	progression	T038	UMLS:C0242656
27924297	144	148	ApoE	T017	UMLS:C1412481
27924297	161	165	mice	T204	UMLS:C0025929
27924297	239	246	in vivo	T082	UMLS:C1515655
27924297	249	258	silencing	T038	UMLS:C0598496
27924297	262	266	CD40	T017	UMLS:C1539081
27924297	275	286	progression	T038	UMLS:C0242656
27924297	290	302	experimental	T062	UMLS:C0681814
27924297	303	316	atherogenesis	T038	UMLS:C1563937
27924297	327	331	NFκB	T103	UMLS:C0079904
27924297	334	342	miR-125b	T103	UMLS:C2352284
27924297	374	383	mediators	T103	UMLS:C1363844
27924297	391	403	pathogenesis	T038	UMLS:C0699748
27924297	407	422	atherosclerosis	T038	UMLS:C0003850
27924297	426	434	M. Hueso	T170	UMLS:C1547383
27924297	436	447	L. De Ramon	T170	UMLS:C1547383
27924297	449	459	E. Navarro	T170	UMLS:C1547383
27924297	461	470	E. Ripoll	T170	UMLS:C1547383
27924297	472	484	J.M. Cruzado	T170	UMLS:C1547383
27924297	486	497	J.M. Grinyo	T170	UMLS:C1547383
27924297	499	508	J. Torras	T170	UMLS:C1547383
27924297	543	553	validation	T062	UMLS:C1519941
27924297	561	570	silencing	T038	UMLS:C0598496
27924297	574	578	CD40	T017	UMLS:C1539081
27924297	579	589	expression	T038	UMLS:C0017262
27924297	606	611	siRNA	T103	UMLS:C1099354
27924297	615	624	ApoE(-/-)	T017	UMLS:C1412481
27924297	625	630	mouse	T204	UMLS:C0025929
27924297	631	637	aortas	T017	UMLS:C0003483
27924297	667	674	splenic	T017	UMLS:C0037993
27924297	675	701	lymphocytic subpopulations	T170	UMLS:C0079720
27924297	720	732	infiltration	T038	UMLS:C0332448
27924297	736	749	aortic intima	T017	UMLS:C0226009
27924297	753	761	F4/80(+)	T017	UMLS:C0007634
27924297	763	788	galectin-3(+) macrophages	T017	UMLS:C0024432
27924297	795	809	NF-κB(+) cells	T017	UMLS:C0007634
27924297	840	853	Gene Ontology	T170	UMLS:C1138831
27924297	858	871	TLDA analysis	T062	UMLS:C0936012
27924297	890	899	detection	T058	UMLS:C1511790
27924297	913	922	mediators	T103	UMLS:C1363844
27924297	926	941	atherosclerosis	T038	UMLS:C0003850
27924297	942	953	progression	T038	UMLS:C0242656
27924297	1005	1010	genes	T017	UMLS:C0017337
27924297	1017	1027	expression	T038	UMLS:C0017262
27924297	1048	1063	atherosclerosis	T038	UMLS:C0003850
27924297	1064	1075	progression	T038	UMLS:C0242656
27924297	1080	1093	downregulated	T038	UMLS:C0013081
27924297	1099	1103	CD40	T017	UMLS:C1539081
27924297	1104	1113	silencing	T038	UMLS:C0598496